Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Benjamin Morgan Scirica, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lau ES, Scirica B, Schaefer IM, Miller AL, Loscalzo J. Hypertensive Heartbreak. N Engl J Med. 2021 06 03; 384(22):2145-2152. PMID: 34077647.
    Citations:    Fields:    Translation:Humans
  2. Lau ES, Vaidya A, Schaefer IM, Scirica BM. Hypertensive Heartbreak. N Engl J Med. 2021 May 27; 384(21):e80. PMID: 34042392.
    Citations:    Fields:    Translation:Humans
  3. Berg DD, Freedman BL, Bonaca MP, Jarolim P, Scirica BM, Goodrich EL, Sabatine MS, Morrow DA. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50. J Am Heart Assoc. 2021 May 04; 10(9):e018673. PMID: 33884889.
    Citations: 1     Fields:    
  4. Cavallari I, Bhatt DL, Steg PG, Leiter LA, McGuire DK, Mosenzon O, Im K, Raz I, Braunwald E, Scirica BM. Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial. J Am Coll Cardiol. 2021 Apr 13; 77(14):1837-1840. PMID: 33832610.
    Citations:    Fields:    
  5. Zelniker TA, Morrow DA, Scirica BM, Furtado JD, Guo J, Mozaffarian D, Sabatine MS, O'Donoghue ML. Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36. J Am Heart Assoc. 2021 Apr 20; 10(8):e017401. PMID: 33840228.
    Citations: 1     Fields:    
  6. Smith KV, Dunning JR, Fischer CM, MacLean TE, Bosque-Hamilton JW, Fera LE, Grant JY, Zelle DJ, Matta L, Gaziano TA, MacRae CA, Scirica BM, Desai AS. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. J Pharm Pract. 2021 Apr 05; 8971900211004840. PMID: 33813934.
    Citations:    Fields:    
  7. Nassif ME, Windsor SL, Tang F, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Austin B, Fong MW, LaRue SJ, Umpierrez G, Hartupee J, Khariton Y, Malik AO, Ogunniyi MO, Wenger NK, Kosiborod MN. Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes Obes Metab. 2021 06; 23(6):1426-1430. PMID: 33606921.
    Citations:    Fields:    Translation:Humans
  8. Wise RA, Chapman KR, Scirica BM, Daoud SZ, Lythgoe D, Garcia-Gil E. The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial. Int J Chron Obstruct Pulmon Dis. 2021; 16:689-699. PMID: 33776428.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  9. Lau ES, Braunwald E, Morrow DA, Giugliano RP, Antman EM, Gibson CM, Scirica BM, Bohula EA, Wiviott SD, Bhatt DL, Bonaca MP, Cannon CP, Im K, Guo J, Sabatine MS, O'Donoghue ML. Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials. Circulation. 2021 Feb 16; 143(7):685-695. PMID: 33587654.
    Citations:    Fields:    
  10. Marston NA, Melloni GEM, Gurmu Y, Bonaca MP, Kamanu FK, Roselli C, Lee C, Cavallari I, Giugliano RP, Scirica BM, Bhatt DL, Steg PG, Cohen M, Storey RF, Keech AC, Raz I, Mosenzon O, Braunwald E, Lubitz SA, Ellinor PT, Sabatine MS, Ruff CT. Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease. Circ Genom Precis Med. 2021 02; 14(1):e003006. PMID: 33434447.
    Citations:    Fields:    
  11. Desai AS, Maclean T, Blood AJ, Bosque-Hamilton J, Dunning J, Fischer C, Fera L, Smith KV, Wagholikar K, Zelle D, Gaziano T, Plutzky J, Scirica B, MacRae CA. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. 2020 Dec 01; 5(12):1430-1434. PMID: 32936209.
    Citations: 3     Fields:    
  12. Cavender MA, Scirica BM. NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes? Diabetes Care. 2020 12; 43(12):2904-2905. PMID: 33218988.
    Citations:    Fields:    Translation:Humans
  13. Scirica BM, Cannon CP, Fisher NDL, Gaziano TA, Zelle D, Chaney K, Miller A, Nichols H, Matta L, Gordon WJ, Murphy S, Wagholikar KB, Plutzky J, MacRae CA. Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control. Circulation. 2021 Feb 02; 143(5):507-509. PMID: 33201729.
    Citations: 1     Fields:    
  14. Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N Engl J Med. 2021 01 14; 384(2):129-139. PMID: 33200891.
    Citations: 34     Fields:    Translation:HumansCTClinical Trials
  15. Marston NA, Patel PN, Kamanu FK, Nordio F, Melloni GM, Roselli C, Gurmu Y, Weng LC, Bonaca MP, Giugliano RP, Scirica BM, O'Donoghue ML, Cannon CP, Anderson CD, Bhatt DL, Gabriel Steg P, Cohen M, Storey RF, Sever P, Keech AC, Raz I, Mosenzon O, Antman EM, Braunwald E, Ellinor PT, Lubitz SA, Sabatine MS, Ruff CT. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. Circulation. 2021 Feb 02; 143(5):470-478. PMID: 33185476.
    Citations: 2     Fields:    
  16. Ferro EG, Bhatt AS, Zhou G, Fiumara K, Wasfy JH, Sequist TD, Morrow DA, Scirica BM. Practice pattern of use of high sensitivity troponin in the outpatient settings. Clin Cardiol. 2020 Dec; 43(12):1573-1578. PMID: 33089909.
    Citations: 1     Fields:    Translation:Humans
  17. Beuchat I, Sivaraju A, Amorim E, Gilmore EJ, Dunet V, Rossetti AO, Westover MB, Hsu L, Scirica BM, Silva D, Tang K, Lee JW. MRI-EEG correlation for outcome prediction in postanoxic myoclonus: A multicenter study. Neurology. 2020 07 28; 95(4):e335-e341. PMID: 32482841.
    Citations: 1     Fields:    Translation:Humans
  18. Scirica BM, Bergmark BA, Morrow DA, Antman EM, Bonaca MP, Murphy SA, Sabatine MS, Braunwald E, Wiviott SD. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2020 03 17; 75(10):1095-1106. PMID: 32164882.
    Citations: 5     Fields:    Translation:Humans
  19. Vaduganathan M, Singh A, Sharma A, Januzzi JL, Scirica BM, Butler J, Zannad F, McGuire DK, Cannon CP, Bhatt DL. Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk. Am J Cardiol. 2020 05 15; 125(10):1577-1581. PMID: 32245636.
    Citations:    Fields:    Translation:Humans
  20. Qamar A, Morrow DA, Creager MA, Scirica BM, Olin JW, Beckman JA, Murphy SA, Bonaca MP. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial. Vasc Med. 2020 04; 25(2):124-132. PMID: 32000630.
    Citations: 1     Fields:    Translation:Humans
  21. Bergmark BA, Bhatt DL, McGuire DK, Scirica BM. Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial". Circulation. 2020 01 28; 141(4):e57-e58. PMID: 31986098.
    Citations:    Fields:    Translation:Humans
  22. Jacobs CS, Beers L, Park S, Scirica B, Henderson GV, Hsu L, Bevers M, Dworetzky BA, Lee JW. Racial and Ethnic Disparities in Postcardiac Arrest Targeted Temperature Management Outcomes. Crit Care Med. 2020 01; 48(1):56-63. PMID: 31567402.
    Citations:    Fields:    Translation:Humans
  23. Blood AJ, Fischer CM, Fera LE, MacLean TE, Smith KV, Dunning JR, Bosque-Hamilton JW, Aronson SJ, Gaziano TA, MacRae CA, Matta LS, Mercurio-Pinto AA, Murphy SN, Scirica BM, Wagholikar K, Desai AS. Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction. Clin Cardiol. 2020 Jan; 43(1):4-13. PMID: 31725920.
    Citations: 2     Fields:    Translation:Humans
  24. Xu H, Bonaca MP, Goodrich E, Scirica BM, Morrow DA. Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial. Eur Heart J Acute Cardiovasc Care. 2019 Oct 23; 2048872619883354. PMID: 31642690.
    Citations: 1     Fields:    
  25. Xu H, Bonaca MP, Goodrich E, Scirica BM, Morrow DA. Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial. Eur Heart J Acute Cardiovasc Care. 2019 Oct 23. PMID: 33609100.
    Citations:    Fields:    
  26. Ghassemi MM, Amorim E, Alhanai T, Lee JW, Herman ST, Sivaraju A, Gaspard N, Hirsch LJ, Scirica BM, Biswal S, Moura Junior V, Cash SS, Brown EN, Mark RG, Westover MB. Quantitative Electroencephalogram Trends Predict Recovery in Hypoxic-Ischemic Encephalopathy. Crit Care Med. 2019 10; 47(10):1416-1423. PMID: 31241498.
    Citations: 2     Fields:    Translation:Humans
  27. Nassif ME, Windsor SL, Tang F, Khariton Y, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Austin B, Drazner MH, Fong MW, Givertz MM, Gordon RA, Jermyn R, Katz SD, Lamba S, Lanfear DE, LaRue SJ, Lindenfeld J, Malone M, Margulies K, Mentz RJ, Mutharasan RK, Pursley M, Umpierrez G, Kosiborod M. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation. 2019 10 29; 140(18):1463-1476. PMID: 31524498.
    Citations: 55     Fields:    Translation:HumansCTClinical Trials
  28. Ptaszek LM, Baugh CW, Lubitz SA, Ruskin JN, Ha G, Forsch M, DeOliveira SA, Baig S, Heist EK, Wasfy JH, Brown DF, Biddinger PD, Raja AS, Scirica B, White BA, Mansour M. Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi-Center Study. J Am Heart Assoc. 2019 09 17; 8(18):e012656. PMID: 31510841.
    Citations: 2     Fields:    Translation:Humans
  29. Berg DD, Wiviott SD, Scirica BM, Gurmu Y, Mosenzon O, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Johanson P, Johansson PA, Langkilde AM, Raz I, Braunwald E, Sabatine MS. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. Circulation. 2019 11 05; 140(19):1569-1577. PMID: 31474116.
    Citations: 13     Fields:    Translation:Humans
  30. Bergmark BA, Bhatt DL, McGuire DK, Cahn A, Mosenzon O, Steg PG, Im K, Kanevsky E, Gurmu Y, Raz I, Braunwald E, Scirica BM. Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial. Circulation. 2019 09 17; 140(12):1004-1014. PMID: 31362530.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  31. Amorim E, van der Stoel M, Nagaraj SB, Ghassemi MM, Jing J, O'Reilly UM, Scirica BM, Lee JW, Cash SS, Westover MB. Quantitative EEG reactivity and machine learning for prognostication in hypoxic-ischemic brain injury. Clin Neurophysiol. 2019 10; 130(10):1908-1916. PMID: 31419742.
    Citations: 6     Fields:    Translation:Humans
  32. Zelniker TA, Jarolim P, Silverman MG, Bohula EA, Park JG, Bonaca MP, Scirica BM, Morrow DA. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS. Clin Chem Lab Med. 2019 06 26; 57(7):1084-1092. PMID: 30710475.
    Citations: 2     Fields:    Translation:Humans
  33. Wagholikar KB, Fischer CM, Goodson AP, Herrick CD, Maclean TE, Smith KV, Fera L, Gaziano TA, Dunning JR, Bosque-Hamilton J, Matta L, Toscano E, Richter B, Ainsworth L, Oates MF, Aronson S, MacRae CA, Scirica BM, Desai AS, Murphy SN. Phenotyping to Facilitate Accrual for a Cardiovascular Intervention. J Clin Med Res. 2019 Jun; 11(6):458-463. PMID: 31143314.
    Citations: 1     
  34. Zelniker TA, Jarolim P, Scirica BM, Braunwald E, Park JG, Das S, Sabatine MS, Morrow DA. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes. J Am Heart Assoc. 2019 05 07; 8(9):e011444. PMID: 31020897.
    Citations: 3     Fields:    Translation:Humans
  35. Wise RA, Chapman KR, Scirica BM, Bhatt DL, Daoud SZ, Zetterstrand S, Reisner C, Gil EG. Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial. JAMA. 2019 05 07; 321(17):1693-1701. PMID: 31063575.
    Citations: 6     Fields:    Translation:Humans
  36. Wagholikar KB, Ainsworth L, Vernekar VP, Pathak A, Glynn C, Zelle D, Zagade A, Karipineni N, Herrick CD, McPartlin M, Bui TV, Mendis M, Klann J, Oates M, Gordon W, Cannon C, Patel R, Aronson SJ, MacRae CA, Scirica BM, Murphy SN. Extending i2b2 into a framework for semantic abstraction of EHR to facilitate rapid development and portability of Health IT applications. AMIA Jt Summits Transl Sci Proc. 2019; 2019:370-378. PMID: 31258990.
    Citations: 2     
  37. Zelniker TA, Morrow DA, Mosenzon O, Gurmu Y, Im K, Cahn A, Raz I, Steg PG, Leiter LA, Braunwald E, Bhatt DL, Scirica BM. Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53. Clin Chem. 2019 06; 65(6):781-790. PMID: 30988169.
    Citations: 4     Fields:    Translation:Humans
  38. Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598. PMID: 30922481.
    Citations: 7     Fields:    Translation:Humans
  39. Correa S, Bonaca MP, Scirica BM, Murphy SA, Goodrich EL, Morrow DA, O'Donoghue ML. Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function. J Thromb Thrombolysis. 2019 Apr; 47(3):353-360. PMID: 30511258.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  40. Patel SM, Morrow DA, Kidd SK, Goodrich EL, Scirica BM, Bonaca MP. Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial. Vasc Med. 2019 04; 24(2):159-161. PMID: 30868939.
    Citations:    Fields:    Translation:HumansPHPublic Health
  41. Fitchett D, Inzucchi SE, Cannon CP, McGuire DK, Scirica BM, Johansen OE, Sambevski S, Kaspers S, Pfarr E, George JT, Zinman B. Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial. Circulation. 2019 03 12; 139(11):1384-1395. PMID: 30586757.
    Citations: 43     Fields:    Translation:Humans
  42. Baugh CW, Scirica BM, Januzzi JL, Morrow DA, Lewandrowski KB, Jarolim P, White BA, Weinfeld MS, Hoffmann U, Nagurney JT. Implementation of an Emergency Department High-Sensitivity Troponin Chest Pain Pathway in the United States. Crit Pathw Cardiol. 2019 03; 18(1):1-4. PMID: 30747757.
    Citations: 1     Fields:    Translation:Humans
  43. Fisher NDL, Fera LE, Dunning JR, Desai S, Matta L, Liquori V, Pagliaro J, Pabo E, Merriam M, MacRae CA, Scirica BM. Development of an entirely remote, non-physician led hypertension management program. Clin Cardiol. 2019 Feb; 42(2):285-291. PMID: 30582181.
    Citations: 7     Fields:    Translation:Humans
  44. Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. Circulation. 2019 01 15; 139(3):366-375. PMID: 30586726.
    Citations: 8     Fields:    Translation:Humans
  45. Bohula EA, Wiviott SD, Scirica BM. Lorcaserin Safety in Overweight or Obese Patients. N Engl J Med. 2019 01 03; 380(1):100. PMID: 30601747.
    Citations:    Fields:    Translation:Humans
  46. Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372. PMID: 30409566.
    Citations: 16     Fields:    Translation:Humans
  47. Bevers MB, Scirica BM, Avery KR, Henderson GV, Lin AP, Lee JW. Combination of Clinical Exam, MRI and EEG to Predict Outcome Following Cardiac Arrest and Targeted Temperature Management. Neurocrit Care. 2018 12; 29(3):396-403. PMID: 29949008.
    Citations: 3     Fields:    Translation:Humans
  48. Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet. 2018 11 24; 392(10161):2269-2279. PMID: 30293771.
    Citations: 21     Fields:    Translation:Humans
  49. Gutierrez JA, Scirica BM, Bonaca MP, Steg PG, Mosenzon O, Hirshberg B, Im K, Raz I, Braunwald E, Bhatt DL. Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial). Am J Cardiol. 2019 01 01; 123(1):145-152. PMID: 30366601.
    Citations: 4     Fields:    Translation:Humans
  50. Wagholikar KB, Fischer CM, Goodson A, Herrick CD, Rees M, Toscano E, MacRae CA, Scirica BM, Desai AS, Murphy SN. Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF). J Med Syst. 2018 Sep 25; 42(11):209. PMID: 30255347.
    Citations: 7     Fields:    Translation:Humans
  51. Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. N Engl J Med. 2018 09 20; 379(12):1107-1117. PMID: 30145941.
    Citations: 38     Fields:    Translation:Humans
  52. Bergmark BA, Scirica BM, Steg PG, Fanola CL, Gurmu Y, Mosenzon O, Cahn A, Raz I, Bhatt DL. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk. Eur Heart J. 2018 06 21; 39(24):2255-2262. PMID: 29394350.
    Citations: 8     Fields:    Translation:Humans
  53. Scirica BM, Bansilal S, Davoudi F, Armstrong PW, Clare RM, Schulte PJ, Pieper KS, Becker RC, James SK, Storey RF, Steg PG, Held C, Himmelmann A, Mahaffey KW, Wallentin L, Cannon CP. Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis. Am Heart J. 2018 08; 202:54-60. PMID: 29859968.
    Citations:    Fields:    Translation:Humans
  54. Bohula EA, Scirica BM, Fanola C, Inzucchi SE, Keech A, McGuire DK, Smith SR, Abrahamsen T, Francis BH, Miao W, Perdomo CA, Satlin A, Wiviott SD, Sabatine MS. Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial. Am Heart J. 2018 08; 202:39-48. PMID: 29803985.
    Citations: 1     Fields:    Translation:Humans
  55. Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, Im K, Kanevsky E, Stahre C, Sjöstrand M, Raz I, Braunwald E. Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial. JAMA Cardiol. 2018 02 01; 3(2):155-163. PMID: 29214305.
    Citations: 20     Fields:    Translation:Humans
  56. Wise RA, Chapman KR, Scirica BM, Schoenfeld DA, Bhatt DL, Daoud SZ, Seoane B, Reisner C, Garcia Gil E. Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study. Chronic Obstr Pulm Dis. 2018 Jan 24; 5(1):5-15. PMID: 29629400.
    Citations: 2     
  57. Doll JA, Li S, Chiswell K, Roe MT, Kosiborod M, Scirica BM, Wang TY. Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy. Eur Heart J. 2018 01 14; 39(3):193-200. PMID: 28541452.
    Citations:    Fields:    Translation:Humans
  58. Bergmark BA, Bhatt DL, Braunwald E, Morrow DA, Steg PG, Gurmu Y, Cahn A, Mosenzon O, Raz I, Bohula E, Scirica BM. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. 2018 03; 41(3):577-585. PMID: 29196298.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  59. Myers PD, Scirica BM, Stultz CM. Machine Learning Improves Risk Stratification After Acute Coronary Syndrome. Sci Rep. 2017 10 04; 7(1):12692. PMID: 28978948.
    Citations: 5     Fields:    Translation:Humans
  60. Butler J, Hamo CE, Filippatos G, Pocock SJ, Bernstein RA, Brueckmann M, Cheung AK, George JT, Green JB, Januzzi JL, Kaul S, Lam CSP, Lip GYH, Marx N, McCullough PA, Mehta CR, Ponikowski P, Rosenstock J, Sattar N, Salsali A, Scirica BM, Shah SJ, Tsutsui H, Verma S, Wanner C, Woerle HJ, Zannad F, Anker SD. The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. Eur J Heart Fail. 2017 11; 19(11):1390-1400. PMID: 28836359.
    Citations: 39     Fields:    Translation:Humans
  61. Scirica BM, Braunwald E, Bhatt DL. Microangiopathy, Arterial Stiffness, and Risk Stratification in Patients With Type 2 Diabetes-Reply. JAMA Cardiol. 2017 07 01; 2(7):821. PMID: 28296995.
    Citations:    Fields:    
  62. Fantaneanu TA, Sarkis R, Avery K, Scirica BM, Hurwitz S, Henderson GV, Lee JW. Delayed Deterioration of EEG Background Rhythm Post-cardiac Arrest. Neurocrit Care. 2017 Jun; 26(3):411-419. PMID: 28004331.
    Citations: 5     Fields:    Translation:Humans
  63. Bergmark BA, Scirica BM. First, do no (irreparable) harm: infarction, bleeding, and subsequent risk of death. The dangers of false equivalency. Eur Heart J. 2017 03 14; 38(11):811-813. PMID: 28363223.
    Citations:    Fields:    Translation:Humans
  64. Briggs AH, Bhatt DL, Scirica BM, Raz I, Johnston KM, Szabo SM, Bergenheim K, Mukherjee J, Hirshberg B, Mosenzon O. Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial. Diabetes Res Clin Pract. 2017 Aug; 130:24-33. PMID: 28554140.
    Citations: 8     Fields:    Translation:Humans
  65. Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, Crompton AE, Murphy SA, Lanz H, Mercuri MF, Antman EM, Braunwald E. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythm Electrophysiol. 2017 01; 10(1). PMID: 28077507.
    Citations: 24     Fields:    Translation:Humans
  66. Scirica BM. Use of Biomarkers in Predicting the Onset, Monitoring the Progression, and Risk Stratification for Patients with Type 2 Diabetes Mellitus. Clin Chem. 2017 Jan; 63(1):186-195. PMID: 28062618.
    Citations: 9     Fields:    Translation:Humans
  67. Baugh CW, Greenberg JO, Mahler SA, Kosowsky JM, Schuur JD, Parmar S, Ciociolo GR, Carr CW, Ghazinouri R, Scirica BM. Implementation of a Risk Stratification and Management Pathway for Acute Chest Pain in the Emergency Department. Crit Pathw Cardiol. 2016 12; 15(4):131-137. PMID: 27846004.
    Citations: 2     Fields:    Translation:Humans
  68. Scirica BM, Bhatt DL, Braunwald E, Raz I, Cavender MA, Im K, Mosenzon O, Udell JA, Hirshberg B, Pollack PS, Steg PG, Jarolim P, Morrow DA. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2016 Dec 01; 1(9):989-998. PMID: 27681000.
    Citations: 19     Fields:    
  69. Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clin Chem. 2017 Jan; 63(1):307-315. PMID: 28062625.
    Citations: 5     Fields:    Translation:Humans
  70. Bonaca MP, Creager MA, Olin J, Scirica BM, Gilchrist IC, Murphy SA, Goodrich EL, Braunwald E, Morrow DA. Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial. JACC Cardiovasc Interv. 2016 10 24; 9(20):2157-2164. PMID: 27765312.
    Citations: 5     Fields:    Translation:Humans
  71. Mosenzon O, Leibowitz G, Bhatt DL, Cahn A, Hirshberg B, Wei C, Im K, Rozenberg A, Yanuv I, Stahre C, Ray KK, Iqbal N, Braunwald E, Scirica BM, Raz I. Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial. Diabetes Care. 2017 Jan; 40(1):69-76. PMID: 27797925.
    Citations: 55     Fields:    Translation:Humans
  72. Liu Y, Scirica BM, Stultz CM, Guttag JV. Beatquency domain and machine learning improve prediction of cardiovascular death after acute coronary syndrome. Sci Rep. 2016 10 06; 6:34540. PMID: 27708350.
    Citations: 4     Fields:    Translation:Humans
  73. Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, Smith SC, Ohman EM, Scirica BM. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016 09 28; 5(10). PMID: 27680665.
    Citations: 10     Fields:    Translation:Humans
  74. Patel RB, Tannenbaum S, Viana-Tejedor A, Guo J, Im K, Morrow DA, Scirica BM. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care. 2017 Feb; 6(1):18-25. PMID: 26714972.
    Citations: 7     Fields:    Translation:Humans
  75. Kosova EC, Bonaca MP, Dellborg M, He P, Morais J, Oude Ophuis T, Scirica BM, Tendera M, Theroux P, Braunwald E, Morrow DA. Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial. Eur Heart J Acute Cardiovasc Care. 2017 Mar; 6(2):164-172. PMID: 27075924.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  76. Fantaneanu TA, Tolchin B, Alvarez V, Friolet R, Avery K, Scirica BM, O'Brien M, Henderson GV, Lee JW. Effect of stimulus type and temperature on EEG reactivity in cardiac arrest. Clin Neurophysiol. 2016 Nov; 127(11):3412-3417. PMID: 27693940.
    Citations: 6     Fields:    Translation:Humans
  77. Bohula EA, Bonaca MP, Braunwald E, Aylward PE, Corbalan R, De Ferrari GM, He P, Lewis BS, Merlini PA, Murphy SA, Sabatine MS, Scirica BM, Morrow DA. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction. Circulation. 2016 Jul 26; 134(4):304-13. PMID: 27440003.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  78. Bonaca MP, O'Malley RG, Jarolim P, Scirica BM, Murphy SA, Conrad MJ, Cannon CP, White HD, Braunwald E, Morrow DA, Sabatine MS. Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease. J Am Coll Cardiol. 2016 07 19; 68(3):322-323. PMID: 27417011.
    Citations: 5     Fields:    Translation:Humans
  79. Kidd SK, Bonaca MP, Braunwald E, De Ferrari GM, Lewis BS, Merlini PA, Murphy SA, Scirica BM, White HD, Morrow DA. Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50. J Am Heart Assoc. 2016 07 18; 5(7). PMID: 27431644.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  80. Jaffe AS, Morrow DA, Scirica BM. High-Sensitivity Troponin in the Triage of Acute Decompensated Heart Failure. JACC Heart Fail. 2016 07; 4(7):600-602. PMID: 27289402.
    Citations:    Fields:    Translation:Humans
  81. Cahn A, Raz I, Mosenzon O, Leibowitz G, Yanuv I, Rozenberg A, Iqbal N, Hirshberg B, Sjostrand M, Stahre C, Im K, Kanevsky E, Scirica BM, Bhatt DL, Braunwald E. Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial. Diabetes Care. 2016 Aug; 39(8):1329-37. PMID: 27222508.
    Citations: 4     Fields:    Translation:Humans
  82. Fordyce CB, Wang TY, Chen AY, Thomas L, Granger CB, Scirica BM, Henry TD, Wong GC, Ramanathan K, Hansen CM, Kragholm K, Peterson ED, Anderson ML. Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest. J Am Coll Cardiol. 2016 05 03; 67(17):1981-90. PMID: 27126525.
    Citations: 7     Fields:    Translation:Humans
  83. Scirica BM. The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure. JAMA Cardiol. 2016 05 01; 1(2):123-5. PMID: 27437882.
    Citations: 7     Fields:    Translation:Humans
  84. Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8. PMID: 26882019.
    Citations: 1     Fields:    Translation:Humans
  85. Hess CN, Hellkamp AS, Roe MT, Thomas L, Scirica BM, Peng SA, Peterson ED, Wang TY. Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization. J Am Heart Assoc. 2016 Mar 14; 5(3):e002784. PMID: 26976877.
    Citations: 3     Fields:    Translation:Humans
  86. Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, Fang JC, Scirica BM, Henry TD, Granger CB. Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. J Am Coll Cardiol. 2016 Feb 23; 67(7):739-47. PMID: 26892407.
    Citations: 11     Fields:    Translation:Humans
  87. Bui AH, Cannon CP, Steg PG, Storey RF, Husted S, Guo J, Im K, James SK, Michelson EL, Himmelmann A, Held C, Varenhorst C, Wallentin L, Scirica BM. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circ Arrhythm Electrophysiol. 2016 Feb; 9(2):e002951. PMID: 26810596.
    Citations: 4     Fields:    Translation:Humans
  88. Scirica BM. Treating patients with diabetes and cardiovascular disease--Does the glucose matter? Trends Cardiovasc Med. 2016 Feb; 26(2):180-1. PMID: 26830123.
    Citations:    Fields:    Translation:Humans
  89. Bonaca MP, Gutierrez JA, Creager MA, Scirica BM, Olin J, Murphy SA, Braunwald E, Morrow DA. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation. 2016 Mar 08; 133(10):997-1005. PMID: 26826179.
    Citations: 20     Fields:    Translation:Humans
  90. Berg DD, Bonaca MP, Braunwald E, Corbalan R, Goto S, Kiss RG, Murphy SA, Scirica BM, Spinar J, Morrow DA. Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50). Am J Cardiol. 2016 Apr 01; 117(7):1055-8. PMID: 26876014.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  91. Gruberg L, Hellkamp AS, Thomas LE, de Lemos JA, Scirica BM, Hilliard A, Enriquez JR, Mohsen A, Wang TY. The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2015 Dec 28; 8(15):1954-1962. PMID: 26738665.
    Citations: 3     Fields:    Translation:Humans
  92. Baugh CW, Epstein LM, Schuur JD, Novaleski CK, Gayoski DA, Kosowsky JM, Andrews JR, Dwyer RC, Rocchio MA, Culbreth SE, Drane MA, Miller D, Scirica BM. Atrial Fibrillation Emergency Department Observation Protocol. Crit Pathw Cardiol. 2015 Dec; 14(4):121-33. PMID: 26569651.
    Citations:    Fields:    Translation:Humans
  93. Raz I, Cahn A, Mosenzon O, Scirica BM, Bhatt DL. Response to: 'Baseline differences in SAVOR trial'-- prespecified vs. post hoc analysis--a potential source of bias. Diabetes Obes Metab. 2015 Dec; 17(12):1203-4. PMID: 26419822.
    Citations:    Fields:    Translation:Humans
  94. Leiter LA, Teoh H, Mosenzon O, Cahn A, Hirshberg B, Stahre CA, Hoekstra JB, Alvarsson M, Im K, Scirica BM, Bhatt DL, Raz I. Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial. Diabetes Obes Metab. 2016 Feb; 18(2):186-90. PMID: 26443993.
    Citations: 7     Fields:    Translation:Humans
  95. Cavender MA, Scirica BM, Raz I, Steg PG, McGuire DK, Leiter LA, Hirshberg B, Davidson J, Cahn A, Mosenzon O, Im K, Braunwald E, Bhatt DL. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. Am J Med. 2016 Mar; 129(3):340.e1-8. PMID: 26524706.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  96. Scirica BM, Morrow DA. In Search of the 1-Hour Rule-Out for Acute Myocardial Infarction. Clin Chem. 2015 Dec; 61(12):1427-9. PMID: 26503967.
    Citations:    Fields:    Translation:Humans
  97. Silverman MG, Scirica BM. Cardiac arrest and therapeutic hypothermia. Trends Cardiovasc Med. 2016 May; 26(4):337-44. PMID: 26603661.
    Citations: 6     Fields:    Translation:Humans
  98. Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial. Circulation. 2015 Oct 13; 132(15):e198. PMID: 26459088.
    Citations: 15     Fields:    
  99. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention". Circulation. 2015 Sep 22; 132(12):e156. PMID: 26391303.
    Citations:    Fields:    Translation:Humans
  100. Mosenzon O, Wei C, Davidson J, Scirica BM, Yanuv I, Rozenberg A, Hirshberg B, Cahn A, Stahre C, Strojek K, Bhatt DL, Raz I. Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial. Diabetes Care. 2015 Nov; 38(11):2142-50. PMID: 26358285.
    Citations: 20     Fields:    Translation:Humans
  101. Bohula EA, Aylward PE, Bonaca MP, Corbalan RL, Kiss RG, Murphy SA, Scirica BM, White H, Braunwald E, Morrow DA. Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50. Circulation. 2015 Nov 17; 132(20):1871-9. PMID: 26338971.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  102. Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg G, Bhatt DL. Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial". Circulation. 2015 Aug 11; 132(6):e121-2. PMID: 26260506.
    Citations: 4     Fields:    Translation:Humans
  103. Alvarez V, Reinsberger C, Scirica B, O'Brien MH, Avery KR, Henderson G, Lee JW. Continuous electrodermal activity as a potential novel neurophysiological biomarker of prognosis after cardiac arrest--A pilot study. Resuscitation. 2015 Aug; 93:128-35. PMID: 26086420.
    Citations: 7     Fields:    Translation:Humans
  104. Gutierrez JA, Karwatowska-Prokopczuk E, Murphy SA, Belardinelli L, Farzaneh-Far R, Walker G, Morrow DA, Scirica BM. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial. Clin Cardiol. 2015 Aug; 38(8):469-75. PMID: 26059896.
    Citations: 3     Fields:    Translation:Humans
  105. Berg DD, Sukul D, O'Brien M, Scirica BM, Sobieszczyk PS, Olenchock BA, Bohula EA, Morrow DA. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2016 Apr; 5(2):108-16. PMID: 25931573.
    Citations: 2     Fields:    Translation:Humans
  106. Magnani G, Bonaca MP, Braunwald E, Dalby AJ, Fox KA, Murphy SA, Nicolau JC, Oude Ophuis T, Scirica BM, Spinar J, Theroux P, Morrow DA. Efficacy and safety of vorapaxar as approved for clinical use in the United States. J Am Heart Assoc. 2015 Mar 19; 4(3):e001505. PMID: 25792124.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  107. Udell JA, Cavender MA, Bhatt DL, Chatterjee S, Farkouh ME, Scirica BM. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2015 May; 3(5):356-66. PMID: 25791290.
    Citations: 56     Fields:    Translation:Humans
  108. O'Gara PT, Adams JE, Drazner MH, Indik JH, Kirtane AJ, Klarich KW, Newby LK, Scirica BM, Sundt TM. COCATS 4 Task Force 13: Training in Critical Care Cardiology. J Am Coll Cardiol. 2015 May 05; 65(17):1877-86. PMID: 25777649.
    Citations: 6     Fields:    Translation:Humans
  109. Leiter LA, Teoh H, Braunwald E, Mosenzon O, Cahn A, Kumar KM, Smahelova A, Hirshberg B, Stahre C, Frederich R, Bonnici F, Scirica BM, Bhatt DL, Raz I. Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial. Diabetes Care. 2015 Jun; 38(6):1145-53. PMID: 25758769.
    Citations: 19     Fields:    Translation:Humans
  110. Leibowitz G, Cahn A, Bhatt DL, Hirshberg B, Mosenzon O, Wei C, Jermendy G, Sheu WH, Sendon JL, Im K, Braunwald E, Scirica BM, Raz I. Impact of treatment with saxagliptin on glycaemic stability and ß-cell function in the SAVOR-TIMI 53 study. Diabetes Obes Metab. 2015 May; 17(5):487-94. PMID: 25656169.
    Citations: 19     Fields:    Translation:HumansCells
  111. Lawler PR, Silver DA, Scirica BM, Couper GS, Weinhouse GL, Camp PC. Extracorporeal membrane oxygenation in adults with cardiogenic shock. Circulation. 2015 Feb 17; 131(7):676-80. PMID: 25691703.
    Citations: 12     Fields:    Translation:Humans
  112. Cavender MA, Scirica BM, Bonaca MP, Angiolillo DJ, Dalby AJ, Dellborg M, Morais J, Murphy SA, Ophuis TO, Tendera M, Braunwald E, Morrow DA. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial. Circulation. 2015 Mar 24; 131(12):1047-53. PMID: 25681464.
    Citations: 18     Fields:    Translation:HumansPHPublic Health
  113. Kontos MC, Scirica BM, Chen AY, Thomas L, Anderson ML, Diercks DB, Jollis JG, Roe MT. Cardiac arrest and clinical characteristics, treatments and outcomes among patients hospitalized with ST-elevation myocardial infarction in contemporary practice: A report from the National Cardiovascular Data Registry. Am Heart J. 2015 Apr; 169(4):515-22.e1. PMID: 25819858.
    Citations: 6     Fields:    Translation:Humans
  114. Forni AA, Rocchio MA, Szumita PM, Anger KE, Avery KR, Scirica BM. Evaluation of glucose management during therapeutic hypothermia at a Tertiary Academic Medical Center. Resuscitation. 2015 Apr; 89:64-9. PMID: 25600182.
    Citations:    Fields:    Translation:Humans
  115. Shimada YJ, Scirica BM. Long-term management and unmet needs after an acute coronary syndrome event. Am J Cardiol. 2015 Mar 14; 115(5 Suppl):29A-35A. PMID: 25728972.
    Citations:    Fields:    Translation:Humans
  116. Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial. Diabetes Care. 2015 Apr; 38(4):696-705. PMID: 25552421.
    Citations: 46     Fields:    Translation:Humans
  117. Bonaca MP, Scirica BM, Braunwald E, Wiviott SD, Goto S, Nilsen DW, Bonarjee V, Murphy SA, Morrow DA. New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial. J Am Coll Cardiol. 2014 Dec 09; 64(22):2318-26. PMID: 25465417.
    Citations: 11     Fields:    Translation:Humans
  118. Bonaca MP, Scirica BM, Braunwald E, Wiviott SD, O'Donoghue ML, Murphy SA, Morrow DA. Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial. J Am Coll Cardiol. 2014 Dec 09; 64(22):2309-17. PMID: 25465416.
    Citations: 11     Fields:    Translation:Humans
  119. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23; 130(25):2295-301. PMID: 25391519.
    Citations: 22     Fields:    Translation:Humans
  120. Scirica BM, Belardinelli L, Chaitman BR, Waks JW, Volo S, Karwatowska-Prokopczuk E, Murphy SA, Cheng ML, Braunwald E, Morrow DA. Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Europace. 2015 Jan; 17(1):32-7. PMID: 25210025.
    Citations: 10     Fields:    Translation:Humans
  121. Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation. 2014 Oct 28; 130(18):1579-88. PMID: 25189213.
    Citations: 161     Fields:    Translation:Humans
  122. Liu Y, Syed Z, Scirica BM, Morrow DA, Guttag JV, Stultz CM. ECG morphological variability in beat space for risk stratification after acute coronary syndrome. J Am Heart Assoc. 2014 Jun 24; 3(3):e000981. PMID: 24963105.
    Citations: 4     Fields:    Translation:Humans
  123. Varenhorst C, Alström U, Braun OÖ, Storey RF, Mahaffey KW, Bertilsson M, Cannon CP, Scirica BM, Himmelmann A, James SK, Wallentin L, Held C. Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes. Heart. 2014 Nov; 100(22):1762-9. PMID: 24957530.
    Citations: 5     Fields:    Translation:Humans
  124. Raz I, Bhatt DL, Hirshberg B, Mosenzon O, Scirica BM, Umez-Eronini A, Im K, Stahre C, Buskila A, Iqbal N, Greenberger N, Lerch MM. Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptin. Diabetes Care. 2014 Sep; 37(9):2435-41. PMID: 24914244.
    Citations: 14     Fields:    Translation:Humans
  125. Scirica BM. Evaluating the efficacy of mineralocorticoid receptor antagonism in patients with STEMI without heart failure. Eur Heart J. 2014 Sep 07; 35(34):2276-8. PMID: 24780613.
    Citations:    Fields:    Translation:Humans
  126. Nieminen T, Scirica BM, Pegler JR, Tavares C, Pagotto VP, Kanas AF, Sobrado MF, Nearing BD, Umez-Eronini AA, Morrow DA, Belardinelli L, Verrier RL. Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo. Am J Cardiol. 2014 Jul 01; 114(1):17-23. PMID: 24852915.
    Citations: 7     Fields:    Translation:Humans
  127. O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol. 2014 Apr 29; 63(16):1644-53. PMID: 24530676.
    Citations: 24     Fields:    Translation:Humans
  128. Rhee JW, Wiviott SD, Scirica BM, Gibson CM, Murphy SA, Bonaca MP, Morrow DA, Mega JL. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin Cardiol. 2014 Jun; 37(6):350-6. PMID: 24481910.
    Citations: 3     Fields:    Translation:Humans
  129. Scirica BM, Braunwald E, Bhatt DL. Saxagliptin, alogliptin, and cardiovascular outcomes. N Engl J Med. 2014 01 30; 370(5):483-4. PMID: 24476444.
    Citations: 8     Fields:    Translation:Humans
  130. Waks JW, Sabatine MS, Cannon CP, Morrow DA, Gibson CM, Wiviott SD, Giugliano RP, Sloan S, Scirica BM. Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial. Clin Cardiol. 2014 Mar; 37(3):160-6. PMID: 24452727.
    Citations: 1     Fields:    Translation:Humans
  131. Cheezum MK, Bittencourt MS, Hulten EA, Scirica BM, Villines TC, Blankstein R. Coronary computed tomographic angiography in the emergency room: state of the art. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):241-53. PMID: 24417341.
    Citations: 2     Fields:    Translation:Humans
  132. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013 Oct 03; 369(14):1317-26. PMID: 23992601.
    Citations: 870     Fields:    Translation:HumansCTClinical Trials
  133. Wimmer NJ, Scirica BM, Stone PH. The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review. Prog Cardiovasc Dis. 2013 Sep-Oct; 56(2):195-202.